Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Pharmacol Exp Ther
2011 Mar 01;3363:908-15. doi: 10.1124/jpet.110.176255.
Show Gene links
Show Anatomy links
Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition.
Johnstone TB
,
Gu Z
,
Yoshimura RF
,
Villegier AS
,
Hogenkamp DJ
,
Whittemore ER
,
Huang JC
,
Tran MB
,
Belluzzi JD
,
Yakel JL
,
Gee KW
.
???displayArticle.abstract???
α5 Subunit-containing GABA(A) receptors (GABA(A)Rs) and α7 neuronal nicotinic-acetylcholine receptors (nAChRs) are members of the Cys-loop family of ligand-gated ion channels (LGICs) that mediate cognitive and attentional processes in the hippocampus. α5 GABA(A)Rs alter network activity by tonic inhibition of CA1/CA3 pyramidal cells of the hippocampus. Postsynaptic α7 nAChRs in the hippocampus regulate inhibitory GABAergic interneuron activity required for synchronization of pyramidal neurons in the CA1, whereas presynaptic α7 nAChRs regulate glutamate release. Can simultaneous allosteric modulation of these LGICs produce synergistic effects on cognition? We show that combined transient application of two allosteric modulators that individually 1) inhibit α5 GABA(A)Rs and 2) enhance α7 nAChRs causes long-term potentiation (LTP) of mossy fiber stimulation-induced excitatory postsynaptic currents (EPSC) from CA1 pyramidal neurons of rat hippocampal slices. The LTP effect evoked by two compounds is replicated by 3-(2,5-difluorophenyl)-6-(N-ethylindol-5-yl)-1,2,4-triazolo[4,3-b]pyridazine (522-054), a compound we designed to simultaneously inhibit α5 GABA(A)Rs and enhance α7 nAChRs. Selective antagonists for either receptor block sustained EPSC potentiation produced by 522-054. In vivo, 522-054 enhances performance in the radial arm maze and facilitates attentional states in the five-choice serial reaction time trial with similar receptor antagonist sensitivity. These observations may translate into therapeutic utility of dual action compounds in diseases of hippocampal-based cognitive impairment.
Atack,
Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.
2010, Pubmed
Atack,
Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.
2010,
Pubmed
Atack,
In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
2005,
Pubmed
Bonin,
Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons.
2007,
Pubmed
Buccafusco,
Multifunctional receptor-directed drugs for disorders of the central nervous system.
2009,
Pubmed
Buhler,
alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons.
2002,
Pubmed
Caraiscos,
Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors.
2004,
Pubmed
Collinson,
Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.
2002,
Pubmed
Crestani,
Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.
2002,
Pubmed
Fabian-Fine,
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.
2001,
Pubmed
Freedman,
Initial phase 2 trial of a nicotinic agonist in schizophrenia.
2008,
Pubmed
Fritschy,
GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits.
1995,
Pubmed
Ge,
Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation.
2005,
Pubmed
Glykys,
Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?
2008,
Pubmed
Glykys,
Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice.
2006,
Pubmed
Gotti,
Human neuronal nicotinic receptors.
1997,
Pubmed
Gray,
Hippocampal synaptic transmission enhanced by low concentrations of nicotine.
1996,
Pubmed
Green,
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
2005,
Pubmed
Howell,
Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients.
2000,
Pubmed
Huang,
Activation of presynaptic alpha7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic study.
2010,
Pubmed
Hunter,
A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus.
1994,
Pubmed
,
Xenbase
Ji,
Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity.
2001,
Pubmed
Khrestchatisky,
A novel alpha subunit in rat brain GABAA receptors.
1989,
Pubmed
,
Xenbase
Klinkenberg,
The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.
2010,
Pubmed
Lagostena,
The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus.
2008,
Pubmed
Levin,
Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory.
2002,
Pubmed
Levin,
Nicotinic receptor subtypes and cognitive function.
2002,
Pubmed
Li,
Evaluation of native GABA(A) receptors containing an alpha 5 subunit.
2001,
Pubmed
Loveman,
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
2006,
Pubmed
Martin,
Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory.
2010,
Pubmed
McKernan,
GABAA receptor subtypes immunopurified from rat brain with alpha subunit-specific antibodies have unique pharmacological properties.
1991,
Pubmed
Ng,
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.
2007,
Pubmed
,
Xenbase
Nutt,
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist.
2007,
Pubmed
Olincy,
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
2006,
Pubmed
Ortega-Alvaro,
Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
2006,
Pubmed
Picciotto,
Nicotine as a modulator of behavior: beyond the inverted U.
2003,
Pubmed
Pirker,
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
2000,
Pubmed
Rezvani,
Cognitive effects of nicotine.
2001,
Pubmed
Serwanski,
Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain.
2006,
Pubmed
Sternfeld,
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers.
2004,
Pubmed
,
Xenbase
Sur,
Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain.
1999,
Pubmed
Suzdak,
Effects of Ro15-4513 and other benzodiazepine receptor inverse agonists on alcohol-induced intoxication in the rat.
1988,
Pubmed
Suzdak,
A selective imidazobenzodiazepine antagonist of ethanol in the rat.
1986,
Pubmed
Takeda,
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.
2006,
Pubmed
Towers,
Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro.
2004,
Pubmed
Traub,
Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo.
1996,
Pubmed
Tu,
Characterization of a nicotine-sensitive neuronal population in rat entorhinal cortex.
2009,
Pubmed
Whittington,
Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation.
1995,
Pubmed
Wisden,
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon.
1992,
Pubmed
Young,
Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor.
2004,
Pubmed
